Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, [PMID: 28210905] Laboratory literature summary: Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen
Wilding JP
GLOW Peptide Storage & Handling Storage Reference (All Three Compounds) State Lyophilized (Powder Form) BPC-157 -4 F (-20 C) long-term TB-500 -4 F (-20 C) long-term GHK-Cu -4 F (-20 C) long-term State Reconstituted (Liquid Form) BPC-157 35.6-46.4 F (2-8 C), up to 30 days TB-500 35.6-46.4 F (2-8 C), 1-2 weeks GHK-Cu 35.6-46.4 F (2-8 C), up to 30 days State Appearance BPC-157 Clear TB-500 Clear GHK-Cu May be light blue/green State Freeze reconstituted BPC-157 Aliquots possible TB-500 Do not freeze GHK-Cu Do not freeze TB-500 has the shortest reconstituted-stability window
Callahan, B
Importantly, BPC-157 is currently classified as a research peptide
2025, biolongevitylabs.com/research/dsip-delta-sleep-inducing-peptide/?tw_source=google&tw_adid=&tw_campaign=22124776050&tw_kwdid=&gad_source=1&gad_campaignid=22131035699&gbraid=0AAAAA-VNyo4Uc2QKR49_lCuPUVOX6zg2r&gclid=CjwKCAiA_dDIBhB6EiwAvzc1cGN8P24Fn0433DO34wcbGsIJ_fpmMN_5R3L-PEACRcbgLn_HMTZykhoC4zYQAvD_BwE
